Explainer on Africa's Vaccine Production Challenges for Mpox, COVID and Other Diseases

Analysis of Vaccine Production in Africa

The lack of vaccine production capacity in Africa is a pressing issue. Numerous factors contribute to this challenge, including:

• Insufficient funding for health infrastructure.
• Poor governance and regulatory frameworks.
• Limited access to advanced technology.

Impact on Public Health

Without local production of vaccines, the potential to combat diseases like mpox and COVID remains severely hindered. The reliance on external supplies results in:

1. Delayed responses to health crises.
2. Increased vulnerability to pandemics.

For more detailed exploration of vaccine production challenges in Africa, please visit the source.